US5260421A
(en)
*
|
1987-12-21 |
1993-11-09 |
Applied Research Systems Ars Holding N.V. |
Site-directed mutagenesis modified glycoprotein hormones
|
US5792460A
(en)
*
|
1989-02-21 |
1998-08-11 |
Washington University |
Modified glycoprotein hormones having a CTP at the amino terminus
|
US5705478A
(en)
*
|
1989-02-21 |
1998-01-06 |
Washington University |
Covalently linked β subunits of the glycoprotein hormones as antagonists
|
US6225449B1
(en)
*
|
1991-10-04 |
2001-05-01 |
Washington University |
Hormone analogs with multiple CTP extensions
|
US5240832A
(en)
*
|
1989-06-20 |
1993-08-31 |
Genzyme Corporation |
Heteropolymeric protein production methods
|
WO1992022568A1
(en)
*
|
1991-06-18 |
1992-12-23 |
University Of Medicine & Dentistry Of New Jersey |
Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
|
US6028177A
(en)
*
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
US5985611A
(en)
*
|
1992-04-30 |
1999-11-16 |
Washington University |
Recombinant production of gonadotropins in secretory cells
|
DE69422169D1
(de)
*
|
1993-04-20 |
2000-01-20 |
Univ St Louis |
Modifizierte proteine und peptide enthaltende pharmazeutische mittel
|
US5683899A
(en)
|
1994-02-03 |
1997-11-04 |
University Of Hawaii |
Methods and compositions for combinatorial-based discovery of new multimeric molecules
|
US5643745A
(en)
*
|
1994-02-03 |
1997-07-01 |
University Of Hawaii |
Heterologous dimeric proteins produced in heterokaryons
|
US6238890B1
(en)
|
1994-02-18 |
2001-05-29 |
Washington University |
Single chain forms of the glycoprotein hormone quartet
|
GB9403600D0
(en)
*
|
1994-02-24 |
1994-04-13 |
Univ Glasgow |
Three dimensional hormone structure
|
WO1995032216A1
(en)
*
|
1994-05-25 |
1995-11-30 |
University Of Nebraska Board Of Regents |
Biologically active glycoprotein hormones produced in procaryotic cells
|
BR9506313A
(pt)
*
|
1994-08-12 |
1997-08-05 |
Univ Washington |
Formas de cadeia simples do quarteto de hormônio de glicoproteína
|
KR960704932A
(ko)
*
|
1994-08-12 |
1996-10-09 |
에이치. 에스. 리헤이 |
당단백질 호르몬 4개조의 단일-사슬 형태(single-chain forms of the glycoprotein hormone quartet)
|
US5733735A
(en)
*
|
1996-06-11 |
1998-03-31 |
Washington University |
Assay system to determine receptor antagonist target site
|
TW518235B
(en)
*
|
1997-01-15 |
2003-01-21 |
Akzo Nobel Nv |
A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
|
US5883073A
(en)
*
|
1997-04-03 |
1999-03-16 |
Washington University |
Single-chain double-alpha peptide
|
EP1816199A1
(de)
*
|
1997-09-22 |
2007-08-08 |
University of Maryland at Baltimore |
Mutanten von Thyreotropin und darauf basierende Verfahren
|
US6635256B1
(en)
|
1998-10-19 |
2003-10-21 |
Washington University |
Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
|
US6103501A
(en)
*
|
1997-11-17 |
2000-08-15 |
Washington University |
Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
|
BR9913857A
(pt)
|
1998-09-17 |
2001-06-12 |
Lilly Co Eli |
Formulações de proteìna
|
JP2002541213A
(ja)
|
1999-04-13 |
2002-12-03 |
インヘール セラピューティック システムズ, インコーポレイテッド |
不妊症の処置のための乾燥粉末処方物の肺投与
|
EA006605B1
(ru)
*
|
2000-02-22 |
2006-02-24 |
Апплайд Резеч Системз Арс Холдинг Н.В. |
СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ
|
EP1261622B1
(de)
|
2000-02-22 |
2007-03-07 |
Applied Research Systems ARS Holding N.V. |
Gereinigtes recombinantes hlh mit spezifischer bioaktivität und verfahren zu dessen reinigung
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
JP2001333772A
(ja)
|
2000-04-25 |
2001-12-04 |
Washington Univ |
可変性の活性を有する単鎖稔性ホルモン
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US6493964B1
(en)
|
2000-05-25 |
2002-12-17 |
Tousimis Research Corp. |
Supercritical point drying apparatus for semiconductor device manufacturing and bio-medical sample processing
|
ATE320449T1
(de)
*
|
2000-12-11 |
2006-04-15 |
Cheil Jedang Corp |
Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
|
KR101229995B1
(ko)
*
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
US6987172B2
(en)
|
2001-03-05 |
2006-01-17 |
Washington University In St. Louis |
Multifunctional single chain glycoprotein hormones comprising three or more β subunits
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
JP2005509652A
(ja)
*
|
2001-11-08 |
2005-04-14 |
モイル,ウィリアム,アール |
蛋白質の瘤
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
US7173113B2
(en)
*
|
2002-01-31 |
2007-02-06 |
The Trustees Of Columbia University In The City Of New York |
Long-acting hormone and growth factor compositions and uses thereof
|
US7081446B2
(en)
*
|
2002-01-31 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Long-acting follicle stimulating hormone analogues and uses thereof
|
WO2003094858A2
(en)
*
|
2002-05-13 |
2003-11-20 |
Modigenetech Ltd. |
Ctp-extended erythropoietin
|
US20060177894A1
(en)
*
|
2002-11-08 |
2006-08-10 |
Moyle William R |
Protein knobs
|
WO2004078061A2
(en)
|
2003-03-04 |
2004-09-16 |
Aspenbio, Inc. |
Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
|
ATE361092T1
(de)
*
|
2003-07-25 |
2007-05-15 |
Serono Lab |
Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann
|
UA88879C2
(en)
*
|
2003-09-02 |
2009-12-10 |
Эплайд Рисерч Системз Эрс Холдинг Н.В. |
Fsh glycosylation mutant
|
AU2004287645A1
(en)
*
|
2003-11-06 |
2005-05-19 |
Compugen Ltd. |
Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
|
JP4412989B2
(ja)
*
|
2003-12-15 |
2010-02-10 |
株式会社日立製作所 |
複数の記憶システムを有するデータ処理システム
|
US20050220640A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Finkenbinder David B |
Fan motor assembly with noise suppression
|
JP2008508294A
(ja)
*
|
2004-07-27 |
2008-03-21 |
ジェンザイム・コーポレイション |
骨の再生のためのチロトロピンの使用法
|
CA2595695A1
(en)
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
|
US20080039372A1
(en)
*
|
2005-07-21 |
2008-02-14 |
The Trustees Of Columbia University In The City Of New York |
Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation
|
LT1917276T
(lt)
|
2005-08-26 |
2018-05-25 |
Ares Trading S.A. |
Glikozilinto interferono beta gavimo būdas
|
US8604175B2
(en)
*
|
2005-12-09 |
2013-12-10 |
Ares Trading S.A. |
Method for purifying FSH or a FSH mutant
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8048848B2
(en)
*
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8304386B2
(en)
*
|
2006-02-03 |
2012-11-06 |
Prolor Biotech, Inc. |
Long-acting growth hormone and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US7553940B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
EP2203474A1
(de)
*
|
2007-10-22 |
2010-07-07 |
Merck Serono S.A. |
Verfahren zur reinigung von fc-fusionsproteinen
|
AU2008314689A1
(en)
*
|
2007-10-22 |
2009-04-30 |
Merck Serono S.A. |
Method for purifying an Fc-containing protein
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
CN102741422B
(zh)
|
2009-08-24 |
2016-06-08 |
阿穆尼克斯运营公司 |
凝血因子ⅶ组合物及其制备和使用方法
|
AR081755A1
(es)
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
WO2012170969A2
(en)
|
2011-06-10 |
2012-12-13 |
Biogen Idec Ma Inc. |
Pro-coagulant compounds and methods of use thereof
|
EP2729161B1
(de)
|
2011-07-08 |
2018-12-19 |
Bioverativ Therapeutics Inc. |
Chimäre und hybride faktor-viii-polypeptide und verfahren zu ihrer anwendung
|
KR20140053991A
(ko)
|
2011-07-18 |
2014-05-08 |
아츠 바이올로직스 에이/에스 |
장기간 작용하는 황체 형성 호르몬 (lh) 화합물
|
ES2855133T3
(es)
|
2012-02-14 |
2021-09-23 |
Opko Biologics Ltd |
Factores de coagulación de acción prolongada y usos de los mismos
|
JP6383666B2
(ja)
|
2012-02-15 |
2018-08-29 |
バイオベラティブ セラピューティクス インコーポレイテッド |
組換え第viii因子タンパク質
|
JP6256882B2
(ja)
|
2012-02-15 |
2018-01-10 |
アムニクス オペレーティング インコーポレイテッド |
第viii因子組成物、ならびに組成物の作製方法および用途
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
AU2013270683A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Chimeric clotting factors
|
JP2015521589A
(ja)
|
2012-06-08 |
2015-07-30 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
プロコアグラント化合物
|
EP2870250B2
(de)
|
2012-07-06 |
2022-06-29 |
Bioverativ Therapeutics Inc. |
Einkettige faktor-viii-polypeptide exprimierende zelllinie und verwendungen davon
|
WO2014063108A1
(en)
|
2012-10-18 |
2014-04-24 |
Biogen Idec Ma Inc. |
Methods of using a fixed dose of a clotting factor
|
US20150266944A1
(en)
|
2012-10-30 |
2015-09-24 |
Biogen Idec Ma Inc. |
Methods of Using FVIII Polypeptide
|
CA2891393A1
(en)
|
2012-11-20 |
2014-05-30 |
Opko Biologics Ltd. |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
CN103509121B
(zh)
|
2012-11-22 |
2015-01-28 |
苏州康宁杰瑞生物科技有限公司 |
一种fsh融合蛋白及其制备方法和用途
|
WO2014088836A1
(en)
|
2012-12-03 |
2014-06-12 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
EP3889173B1
(de)
|
2013-02-15 |
2023-07-05 |
Bioverativ Therapeutics Inc. |
Optimiertes faktor-viii-gen
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
PT3666283T
(pt)
|
2013-03-15 |
2022-09-13 |
Bioverativ Therapeutics Inc |
Formulações de polipéptido de fator viii
|
CA2899089C
(en)
|
2013-03-15 |
2021-10-26 |
Biogen Ma Inc. |
Factor ix polypeptide formulations
|
EP4108254A1
(de)
|
2013-08-14 |
2022-12-28 |
Bioverativ Therapeutics Inc. |
Rekombinante faktor-viii-proteine
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
EP3060239B1
(de)
|
2013-10-21 |
2020-05-13 |
OPKO Biologics Ltd. |
Polypeptide mit langzeitwirkung sowie verfahren zur herstellung und verabreichung davon
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
CN103539860B
(zh)
*
|
2013-11-01 |
2014-12-03 |
广州优联康医药科技有限公司 |
一种长效重组人促卵泡激素融合蛋白
|
EP3065769A4
(de)
|
2013-11-08 |
2017-05-31 |
Biogen MA Inc. |
Prokoagulatorische fusionsverbindung
|
EP4332839A2
(de)
|
2013-12-06 |
2024-03-06 |
Bioverativ Therapeutics Inc. |
Pharmakokinetische werkzeuge für populationen und verwendungen davon
|
JP7058940B2
(ja)
|
2014-03-24 |
2022-04-25 |
バイオベラティブ セラピューティクス インコーポレイテッド |
凍結乾燥第ix因子製剤
|
US11008561B2
(en)
|
2014-06-30 |
2021-05-18 |
Bioverativ Therapeutics Inc. |
Optimized factor IX gene
|
NZ730563A
(en)
|
2014-10-14 |
2019-05-31 |
Halozyme Inc |
Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
|
MA40835A
(fr)
|
2014-10-23 |
2017-08-29 |
Biogen Ma Inc |
Anticorps anti-gpiib/iiia et leurs utilisations
|
MA40861A
(fr)
|
2014-10-31 |
2017-09-05 |
Biogen Ma Inc |
Anticorps anti-glycoprotéines iib/iiia
|
US20180111974A1
(en)
|
2014-12-10 |
2018-04-26 |
Opko Biologics Ltd. |
Methods of producing long acting ctp-modified growth hormone polypeptides
|
CN108289851B
(zh)
|
2015-06-19 |
2021-06-01 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
BR112018002150A2
(pt)
|
2015-08-03 |
2018-09-18 |
Bioverativ Therapeutics Inc |
proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
|
DK3411478T3
(da)
|
2016-02-01 |
2022-09-12 |
Bioverativ Therapeutics Inc |
Optimerede faktor viii-gener
|
KR102618424B1
(ko)
|
2016-07-11 |
2023-12-26 |
옵코 바이오로직스 리미티드 |
지속성 응고 인자 vii 및 그 제조 방법
|
IL266972B2
(en)
|
2016-12-02 |
2024-04-01 |
Bioverativ Therapeutics Inc |
Methods for the treatment of hemophilic arthritis with the help of chimeric blood coagulation factors
|
BR112019011198A2
(pt)
|
2016-12-02 |
2019-12-17 |
Bioverativ Therapeutics Inc |
métodos de indução de tolerância imune a fatores de coagulação
|
EP3562840A1
(de)
|
2016-12-16 |
2019-11-06 |
Biogen MA Inc. |
Stabilisierter proteolytisch aktivierter wachstumsdifferenzierungsfaktor 11
|
EA201991768A1
(ru)
|
2017-01-31 |
2020-01-22 |
Байоверетив Терапьютикс Инк. |
Слитые белки на основе фактора ix и способы их получения и пути применения
|
CN111247251A
(zh)
|
2017-08-09 |
2020-06-05 |
比奥维拉迪维治疗股份有限公司 |
核酸分子及其用途
|
BR112020015228A2
(pt)
|
2018-02-01 |
2020-12-29 |
Bioverativ Therapeutics Inc. |
Uso de vetores lentivirais que expressam fator viii
|
WO2019211842A1
(en)
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting human growth hormone-antagonists and methods of producing the same
|
MA52630A
(fr)
|
2018-05-18 |
2021-05-26 |
Bioverativ Therapeutics Inc |
Procédés de traitement de l'hémophilie a
|
CN108676096B
(zh)
*
|
2018-05-22 |
2022-03-29 |
北京伟杰信生物科技有限公司 |
重组猪fsh-ctp融合蛋白及其制备方法与应用
|
EP3833766A1
(de)
|
2018-08-09 |
2021-06-16 |
Bioverativ Therapeutics Inc. |
Nukleinsäuremoleküle und verwendungen davon zur nichtviralen gentherapie
|
US20200199626A1
(en)
|
2018-12-06 |
2020-06-25 |
Bioverativ Therapeutics Inc. |
Use of lentiviral vectors expressing factor ix
|
US11254530B2
(en)
*
|
2019-03-26 |
2022-02-22 |
Toshiba Tec Kabushiki Kaisha |
Sheet aligning mechanism
|
EP3969026A1
(de)
|
2019-05-16 |
2022-03-23 |
Ceva Santé Animale |
Zusammensetzungen und verfahren zur erhöhung der reproduktionsleistung bei nichtmenschlichen säugetieren unter verwendung des rekombinanten luteinisierenden hormons
|
WO2021005604A1
(en)
|
2019-07-11 |
2021-01-14 |
Opko Biologics Ltd. |
Long-acting igf-1 or igf-1 variants and methods of producing same
|
US20210113634A1
(en)
|
2019-09-30 |
2021-04-22 |
Bioverativ Therapeutics Inc. |
Lentiviral vector formulations
|
EP4192495A1
(de)
|
2020-08-07 |
2023-06-14 |
Bristol-Myers Squibb Company |
Fgf21 in kombination mit ccr2/5-antagonisten zur behandlung von fibrose
|
US20240123031A1
(en)
|
2020-11-25 |
2024-04-18 |
Bristol-Myers Squibb Company |
Methods of treating liver diseases
|